Pyc Therapeutics Ltd has released a press release.
Shareholder Update
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Operational Update
- Chief Executive Officer Resignation
- Cell-Penetrating Phylomers Improve Delivery of Drugs
- R&D Tax Rebate
- Phylogica Signs Agreement with MedImmune / AstraZeneca
Later from PYC Therapeutics
- AGM Presentation to Shareholders
- NHMRC Grant Awarded to Collaborators
- Genentech extends research collaboration period
- Response to ASX Price Query
- Operational Update March Quarter
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics